Loading
Insider Decl.
97
Thresholds
n/a
Buy Volume
€13,879
2 ops. · all time
Sell Volume
€12,228
1 ops. · all time
Financial data
as of FY 2025FY ended December 2025 · cache
CA$14.58
Analyst consensus
Income statement
RevenueCA$5.6M
Net incomeCA$5M90.5% margin
Balance sheet & cash
Market capCA$19.1M
Free Cash Flow-CA$890.1k
Last declaration on 19 January 2024
Declarations97 total
100 sharesCommon Shares Class A SharesTSXSEDI:4245718
100 sharesCommon Shares Class A SharesTSXSEDI:4245717
1,600 sharesCommon Shares Class A SharesTSXSEDI:4245488
1,600 sharesCommon Shares Class A SharesTSXSEDI:4245489
2,000 sharesCommon Shares Class A SharesTSXSEDI:4197748
2,000 sharesCommon Shares Class A SharesTSXSEDI:4197773
2,000 sharesCommon Shares Class A SharesTSXSEDI:4197772
200 sharesCommon Shares Class A SharesTSXSEDI:4196941
200 sharesCommon Shares Class A SharesTSXSEDI:4196942
900 sharesCommon Shares Class A SharesTSXSEDI:4196658
900 sharesCommon Shares Class A SharesTSXSEDI:4196659
400 sharesCommon Shares Class A SharesTSXSEDI:4193385
400 sharesCommon Shares Class A SharesTSXSEDI:4193383
400 sharesCommon Shares Class A SharesTSXSEDI:4190180
400 sharesCommon Shares Class A SharesTSXSEDI:4190179
11,000 sharesCommon Shares Class A SharesTSXSEDI:4187244
11,000 sharesCommon Shares Class A SharesTSXSEDI:4187241
7,500 sharesCommon Shares Class A SharesTSXSEDI:4183276
7,500 sharesCommon Shares Class A SharesTSXSEDI:4183275
400 sharesCommon Shares Class A SharesTSXSEDI:4181320
400 sharesCommon Shares Class A SharesTSXSEDI:4181323
500 sharesCommon Shares Class A SharesTSXSEDI:4178917
500 sharesCommon Shares Class A SharesTSXSEDI:4178915
1,000 sharesCommon Shares Class A SharesTSXSEDI:4175357
1,000 sharesCommon Shares Class A SharesTSXSEDI:4175358
25 of 97 declarations
About Big Pharma Split Corp.
In the Big Pharma Split Corp. record, 74 of the 78 filings are lodged by the issuer itself, filed as Issuer, with no purchase or sale. The record has 75 filings of a kind other than purchase or sale, and 62 filings in 2023, against 5 in 2018, 3 in 2019, 2 in 2020, 2 in 2021 and 4 in 2024. The open-market trades are the work of a single director and officer, Michael Kovacs, who has 4 filings: 2 purchases, EUR 9,385 on January 26, 2018 and EUR 4,494 on August 17, 2018, or EUR 13,879 in total, and 1 sale of EUR 12,228 on October 7, 2019. Purchases are 67% of open-market trades. Transactions run from September 25, 2017 to January 18, 2024, published a median of 3 days after the trade. Listed on the Toronto stock exchange, the company has a market capitalisation of CAD 19.1 million and no longer has a filing in the last twelve months. Only 2 filers appear: the issuer and Michael Kovacs.
